Neuberger High Yield Strategies Fund Inc Rights (expiring April 15, 2026)
NHS.RT
NHS.RT was delisted on the 14th of April, 2026.
0 hedge funds and large institutions have $0 invested in Neuberger High Yield Strategies Fund Inc Rights (expiring April 15, 2026) in 2026 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 42 closing their positions.
100% less funds holding
Funds holding: 43 → 0 (-43)
100% less capital invested
Capital invested by funds: $46.1K → $0 (-$46.1K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 42
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$5.14K |
| 2 |
CCC
Cable Car Capital
San Francisco,
California
|
-$4.4K |
| 3 |
BFM
Boothbay Fund Management
New York
|
-$3.93K |
| 4 |
QL
Quarry LP
New York
|
-$3.93K |
| 5 |
LPL Financial
San Diego,
California
|
-$3.9K |
NHS.RT Hedge Fund Activity: Q2 2026 in Review
0 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Neuberger High Yield Strategies Fund Inc Rights (expiring April 15, 2026) (NHS.RT) for Q2 2026, worth a combined $0 — down 100% from $46.1K a quarter earlier.
Sellers outnumbered buyers: 42 funds closed out of NHS.RT and 0 opened new positions — a net loss of 42 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Morgan Stanley, exiting entirely with an estimated $5.14K sold.
- 0 institutional investors held Neuberger High Yield Strategies Fund Inc Rights (expiring April 15, 2026) (NHS.RT) as of Q2 2026, down from 43 in Q1 2026.
- Funds reported $0 of Neuberger High Yield Strategies Fund Inc Rights (expiring April 15, 2026) stock for Q2 2026, down 100% quarter-over-quarter.
- 0 funds opened new Neuberger High Yield Strategies Fund Inc Rights (expiring April 15, 2026) positions in Q2 2026 and 42 closed out, a net change of -42 holders.
- The largest Neuberger High Yield Strategies Fund Inc Rights (expiring April 15, 2026) seller in Q2 2026 was Morgan Stanley, an estimated $5.14K sold.
Based on aggregated 13F filings for Q2 2026.